FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1919-1920 June 13, 2002 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: As part of the debate about the safety of calcium-channel blockers in the late 1990s, the Journal published an article in which reference was made to a Canadian Broadcasting Corporation television program (The Fifth Estate) about Health Canada's review of calcium-channel antagonists.¹ The article repeated the false allegation on The Fifth Estate program that an academic advisor to Health Canada "had financial relationships with manufacturers of calcium-channel antagonists," raising "an important question about physicians' objectivity in assessing the safety of drugs." The article did not consider it necessary to mention that, as one of the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Hochwald, S. N., Hemming, A. W., Draganov, P., Vogel, S. B., Dixon, L. R., Grobmyer, S. R. (2008). Elevation of Serum IgG4 in Western Patients With Autoimmune Sclerosing Pancreatocholangitis: A Word of Caution. Ann. Surg. Oncol. 15: 1147-1154 [Abstract] [Full Text]